Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

The Pharmaceuticals Consumer - US

Published by: Mintel International Group Ltd.

Published: Feb. 1, 2008 - 98 Pages


Table of Contents


SCOPE AND THEMES

What you need to know

Definition

Data for this report

Abbreviations and terms

Abbreviations

Terms

Executive Summary, Part I: Market Wide Issues

Access to healthcare the primary obstacle to increased sales

Consumers losing faith in pharmaceutical companies

OTC and Rx medication increasingly competitive

Attentiveness to advertising dependent on prevalence of condition

Younger respondents more attentive, but less able to receive prescriptions

Consumers more active in researching conditions and treatments

Selling the branded product when generics are available

Healthcare Coverage

Introduction

Access to healthcare coverage

Figure 1: Access to health insurance, November 2007, and May 2006-June 2007

Figure 2: Rx prevalence of usage, by type of medical insurance, November 2007

Distrust of Pharmaceutical Companies

Consumer distrust of pharmaceutical companies

Figure 3: Attitudes toward prescription medicine, by availability of medical insurance, November 2007

Trust for pharmaceutical ads by age

Figure 4: Attitudes regarding trust and pharmaceutical companies, by age, November 2007

Doctors reject pharmaceutical sales tactics

Consumer attitudes toward their doctors

Figure 5: Attitudes towards doctors’ roles in choosing pharmaceuticals, June 2002-May 2003, and May 2006 to June 2007

Fear of side effects

Figure 6: Attitudes regarding side effects of drugs, by gender, May 2006 to June 2007

Attitudes to media presentation of side effects

Figure 7: Attitudes regarding the presentation of side effects in D2C advertising, by age, November 2007

Competition from OTC medication

Preferences between OTC and Rx medication

Figure 8: Attitudes toward OTC medicine, by age, May 2006 to June 2007

Figure 9: Choice of OTC medicine over prescription, by age, November 2007

Comparison of Rx usage across illnesses in the Internet population

Figure 10: Use of prescription medication, by condition, November 2007

Competition from/Attitudes to Alternative Medicine

Figure 11: Attitudes toward alternative medicine, June 2002-May 2003, May 2004-May 2005, May 2006 to June 2007

Figure 12: Attitudes toward alternative medicine, by age, November 2007

Attentiveness to Advertising

Introduction

Figure 13: Paying attention to D2C advertising, by type of medication, November 2007

Figure 14: Attentiveness to pharmaceutical ads, by gender, November 2007

Figure 15: Attentiveness to pharmaceutical ads, by age, November 2007

Figure 16: Attentiveness to pharmaceutical ads, by race/ethnicity, November 2007

Figure 17: Attentiveness to pharmaceutical ads, by student status, November 2007

Why ads are watched

Figure 18: Reasons for watching drug ads, November 2007

Figure 19: Reasons for watching drug ads, by age, November 2007

The Consumer’s Research Process

General health research

Figure 20: Ways of reseaching health information, by gender, May 2006 to June 2007

Figure 21: Ways of researching health information, 2003 vs. 2007

Figure 22: Ways of researching health information, by age, May 2006-June 2007

Researching healthcare treatments

Figure 23: Researching pharmaceuticals and treatments, 2003 vs. 2007

Figure 24: Researching pharmaceuticals and treatments, by gender, May 2006 to June 2007

Buying Generic vs. Brand Name

Figure 25: Attitudes to brand-name drugs, May 2006 to June 2007

Figure 26: Attitudes towards name brand and generic drugs, November 2007

Figure 27: Attitudes towards name brand and generic drugs, by race/ethnicity, November 2007

Executive Summary, Part II: Prevalence of Treatment of Specific Conditions

Use of Rx medication varies based on effectiveness of OTC treatment

Substantial opportunity exists in overweight/obesity and herpes

Potential for viral marketing apparent

Depression category leads in sales, sleep aids in ad spend

Sexual dysfunction is not gender-specific

Some suffering from allergies not aware that they have them

Psychiatric medications continue to face obstacles

A large body of sufferers is not being treated in every condition

Making men comfortable talking about depression

Where does trouble concentrating end and ADHD begin?

Bulleted check list for websites

Prevalence of Conditions and Use of Rx Treatments

Introduction

Figure 28: Prevalence of ailments trended and percentage with ailments using prescription medication, 2003-07

Substantial opportunity in drugs to combat obesity

Prescription drug use for allergies declining

Emphasis on responsibility should grow herpes market

Depression: Penetration says more about the competition than about the drug

Internet population

Figure 29: Ailments, have, have had, or friend or family has, November 2007, and May 2006 to june 2007

Comparison of Rx usage across conditions

Figure 30: Use of prescription medication by condition, November 2007 (GF) and May 2006-June 2007 (NCS)

Prevalence of conditions suffered in Internet population by demographics

Figure 31: Conditions suffered (self-reported), by age, November 2007

Figure 32: Conditions suffered (self-reported), by gender, November 2007

Figure 33: Conditions suffered (self-reported), by household income, November 2007

Figure 34: Conditions suffered (self-reported), by race/Hispanic origin, November 2007

Sales and Advertising Spend

Sales

Figure 35: Sales of 20 leading pharmaceutical products for six conditions, 2004 and 2006

Depression medication sales

ADHD medication

Allergy medications

Sleep medications

Figure 36: Ad spend on sleep medication, 2005 and 2006

Sexual Dysfunction

Introduction

Figure 37: Suffer or have suffered from sexual dysfunction, by demographic, November 2007

Treatment of sexual dysfunction

Figure 38: Sexual dysfunction treatment used, by household income, November 2007

Sexual dysfunction medications

Viagra

Figure 39: Pfizer Viagra Advertisement

Levitra

Figure 40: Bayer Levitra Advertisement

Cialis

Figure 41: Lilly Cialis Advertisement

Pollen Allergies

Introduction

Figure 42: Suffered from nasal allergies/hay fever in last 12 months, by demographic, May 2006 to June 2007

Treatment of allergies

Figure 43: Nasal allergy treatment used, by age, November 2007

Figure 44: Allergy treatment used, by race/Hispanic origin, November 2007

Notes on OTC treatment

Allergy shots

Nasal airway surgeries

Allergy medications

Nasonex

Figure 45: Schering-Plough Nasonex Advertisement

Allegra

Clarinex

Flonase

Overweight and Obesity

Introduction

Figure 46: Prevalence of being 30 pounds overweight in the last 12 months, by key demographics, May 2006 to June 2007

Xenical

Competition from gastric bypass surgery

Attitudes Towards Sleep Aids and Psychiatric Drugs

Figure 47: Attitudes towards psychiatric illnesses and drugs and sleep aids, November 2007

Depression

Introduction

Prevalence and treatment with Rx medication by demographic

Figure 48: Incidence of depression, and Rx treatment, by demographic, November 2007, and May 2006-June 2007

Rx vs. other methods of treatment

Figure 49: Depression treatment used, by age, November 2007

Figure 50: Depression treatment used, by race/ethnicity, November 2007

Switching depression medication

Figure 51: Reasons to change depression medication, by age, November 2007

Depression medications

Effexor

Figure 52: Effexor advertisement

Zoloft

Wellbutrin

Cymbalta

Figure 53: Eli Lilly Cymbalta Advertisement

Anxiety

Introduction

Figure 54: Suffer or have suffered from general or social anxiety, by demographic, November 2007, and May 2006-June 2007

Treatment of general anxiety

Figure 55: General anxiety treatment used, by age, November 2007

Treatment of social anxiety

Figure 56: Social anxiety treatment used, by race/ethnicity, November 2007

Switching anxiety medication

Figure 57: Reasons to change anxiety medication, November 2007

Adhd

Prevalence

Figure 58: Suffers or has suffered from ADHD or trouble concentrating, by age, November 2007

Treatment of ADHD

Figure 59: ADHD treatment used, by age, November 2007

ADHD medications

Concerta

Adderall XR

Strattera

Sleep Disorders

Introduction

Figure 60: Suffered from sleep disorders in last 12 months, by age and gender, May 2006 to June 2007, and November 2007

Treatment of sleep-related problems

Figure 61: Sleep-related problem treatment used, by gender, November 2007

Figure 62: Sleep disorder treatment used, by age, November 2007

Treatments for sleep apnea

Sleep disorder medications

Lunesta

Figure 63: Sepracor Lunesta Advertisement

Ambien

Figure 64: Sanofi-Aventis Ambien CR Advertisement

Figure 65: Sanofi-Aventis Ambien CR Advertisement

Rozerem

Requip

Figure 66: GlaxoSmithKline Requip Advertisement

Appendix: Trade Associations

Abstract

In spite of the enormous successes in the market for life-enhancing prescription medication, the industry is plagued by a wide variety of issues that prevent increased sales, ranging from mistrust of pharmaceutical companies, increasing reluctance on the part of physicians to meet with drug company representatives, lack of awareness regarding some illnesses, fear of side effects, concerns regarding effectiveness of products, lack of access to healthcare, as well as fears that pharmaceutical products may be addictive. This Mintel report focuses on methodologies for combating all of these issues via examination of consumer attitudes toward the use of pharmaceuticals in combating the following illnesses:
  • Depression
  • General anxiety
  • Social anxiety
  • ADHD
  • Sexual dysfunction
  • Insomnia
  • Allergies
  • Obesity
The report is divided in two sections, with the first dealing with market-wide issues relevant to the sales of pharmaceuticals, including distrust of pharmaceutical companies, access to medical insurance that covers pharmaceuticals, competition from OTC, generic, and alternative medication, attentiveness to D2C advertising, and the consumer’s research process. The second half of the report focuses on the prevalence, treatment, and potential sales growth for prescription medication by specific conditions.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008